BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 201.4 SEK 0.6%
Market Cap: 17.8B SEK

Wall Street
Price Targets

BIOA B Price Targets Summary
BioArctic AB

There are no price targets for BIOA B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioArctic AB Competitors:
Price Targets
LGND
Ligand Pharmaceuticals Inc
41% Upside
ORY
Oryzon Genomics SA
152% Upside
PRLD
Prelude Therapeutics Inc
283% Upside
ASND
Ascendis Pharma A/S
30% Upside
IMMX
Immix Biopharma Inc
247% Upside
IMAB
I-Mab
152% Upside
BBIO
BridgeBio Pharma Inc
62% Upside
ORKA
Oruka Therapeutics Inc
250% Upside

Revenue
Forecast

Revenue Estimate
BioArctic AB

For the last 8 years the compound annual growth rate for BioArctic AB's revenue is 12%. The projected CAGR for the next 3 years is 97%.

12%
Past Growth
97%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioArctic AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
BioArctic AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOA B's stock price target?
Not Available

BIOA B doesn't have any price targets made by Wall Street professionals.

What is BioArctic AB's Revenue forecast?
Projected CAGR
97%

For the last 8 years the compound annual growth rate for BioArctic AB's revenue is 12%. The projected CAGR for the next 3 years is 97%.

Back to Top